Khayla McClinton, a master’s student in the Institute for Biomedical Sciences, spent her summer at the Chan Zuckerberg Biohub in San Francisco, participating in projects related to data science, biomedical research and biomedical engineering.
Michal Kuczma, a research assistant professor in the Institute for Biomedical Sciences, has received a Career Development Award from the Crohn’s and Colitis Foundation to study environmental influences on gut microbiota, immunity and inflammation.
The award will support interdisciplinary research to build causal learning models that can produce a blueprint of how brain regions interact.
Professor Christopher Basler has received two grants from the National Institutes of Health to study two coronaviruses that cause human disease: Middle East respiratory syndrome (MERS) coronavirus and SARS-CoV-2.
Georgia State will be responsible for the learning analytics portion of the project, a collaborative effort by Georgia universities and other partners.
Compounds targeting two key enzymes are potent inhibitors of SARS-CoV-2, the virus that causes COVID-19, according to a study led by the Institute for Biomedical Sciences at Georgia State.
Robert Hatcher’s (B.A. ’17, MBA ’20) company, Aurign, uses data and technology to make sure musicians and producers get the royalties they’ve rightfully earned.
Georgia State Alumni Association 40 Under 40 honoree and rocket scientist Kavya Manyapu has been tapped to work with NASA’s Artemis program.
An award-winning play about a computer programmer gets turned into an interactive live experience with the help of Georgia State.
An influenza vaccine that is made of nanoparticles and administered through the nose enhances the body’s immune response to influenza virus infection and offers broad protection against different viral strains, according to researchers in the Institute for Biomedical Sciences at Georgia State University.
